India’s air force has surpassed China to become the world’s third strongest aerial power globally, as per the latest rankings ...
Adding nimotuzumab to post-surgery adjuvant cisplatin-based chemoradiotherapy does not improve survival outcomes in patients with HNSCC.
AstraZeneca and Amgen's Tezspire (tezepelumab) has been approved in the US for the add-on maintenance treatment of adult and ...
At the ESMO 2025 annual meeting, Dr. Hansen and colleagues presented the first-in-human data of 212 Pb-ADVC001 in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback